On November 30, 2022 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following conferences (Press release, Iovance Biotherapeutics, NOV 30, 2022, View Source [SID1234624606]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Piper Sandler 34th Annual Healthcare Conference
Fireside Chat: November 30, 2022 at 10:30 a.m. ET / 7:30 a.m. PT
New York, NY
JMP Securities Hematology and Oncology Summit
Fireside Chat: December 7, 2022 at 11:00 a.m. ET / 8:00 a.m. PT
Virtual
41st Annual J.P. Morgan Healthcare Conference
Presentation/Q&A: January 11, 2023 at 11:15 a.m. ET / 8:15 a.m. PT
San Francisco, CA
The live and archived webcasts will be available at View Source